UNSPSC 51284143: Cefteram pivaloyloxymethyl ester

This classification denotes a cephalosporin antibiotic with the molecular formula C22H27N9O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0OD86RT58C, chemically known as pivaloyloxymethyl (z)-7-(2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-(5-methyl-2h-tetrazol-2-ylmethyl)-3-cephem-4-carboxylate, but more generally known as cefteram pivaloyloxymethyl ester, which bears US NIH Compound Identifier 6917871.

European Medicines Agency schedules cefteram pivaloyloxymethyl ester or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07423MIG. Most nations, for tariff purposes, schedule cefteram pivaloyloxymethyl ester under HS 29419000. SMILES: CC1NNN(N1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4CSC(N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C.

UNSPSC 51284143 Cefteram pivaloyloxymethyl ester is a Commodity code that nominally names a specific pharmaceutical compound, but the recent state and local solicitations tagged under this code do not reflect pharmaceutical-specific procurement activity aligned with that narrow product name. The opportunities on record show acquisition of naloxone, safe drug deactivation systems, doxycycline hyclate, and ciprofloxacin hydrochloride through piggyback and direct competitive bidding processes, indicating that the code is being applied at the state and county level to cover a broader range of pharmaceutical and medical supply procurement rather than the cephalosporin ester specified in the code name. State and local health departments and county public health agencies are the primary issuing bodies using this code; the Illinois Department of Public Health and Seminole County, Florida appear in the recent record.

Activity under this code is concentrated in Florida and Illinois, with Seminole County posting a competitive bid in 2026 for naloxone and drug deactivation systems and the Illinois Department of Public Health awarding a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026. The Illinois contract, Solicitation Number 26482DPHPREPDB53392, covered doxycycline hyclate and ciprofloxacin hydrochloride in a 12-month initial term with renewal options, totaling $2,999,999.11 over the life of the contract; that award is now closed. The Seminole County opportunity (IFB60459723LAS), posted June 30, 2026 with a due date of July 26, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, with a two-year initial term and one-year renewal option.